DSM Income Statement

Financials in millions USD. Fiscal year is December - November.

Millions USD. Fiscal year is Dec - Nov.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '25 Nov 30, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021
Other Revenue	22.76	22.25	20.43	21.58	22.74
Revenue	22.76	22.25	20.43	21.58	22.74
Revenue Growth (YoY)	2.33%	8.90%	-5.36%	-5.08%	-11.00%
Gross Profit	22.76	22.25	20.43	21.58	22.74
Selling, General & Admin	2.78	2.9	2.81	3.1	3.47
Operating Expenses	2.78	2.9	2.81	3.1	3.47
Operating Income	19.99	19.35	17.61	18.49	19.27
Interest Expense	-5.88	-6.65	-5.08	-1.98	-1.05
EBT Excluding Unusual Items	14.11	12.7	12.53	16.5	18.22
Gain (Loss) on Sale of Investments	-19.62	19.71	-3.44	-87.95	6.79
Pretax Income	-5.52	32.4	9.09	-71.45	25.02
Net Income	-5.52	32.4	9.09	-71.45	25.02
Preferred Dividends & Other Adjustments	-	-	1.75	0.81	0.05
Net Income to Common	-5.52	32.4	7.34	-72.26	24.96
Net Income Growth	-	256.43%	-	-	62.28%
Shares Outstanding (Basic)	49	49	49	49	49
Shares Outstanding (Diluted)	49	49	49	49	49
Shares Change (YoY)	-	-	-	0.01%	-
EPS (Basic)	-0.11	0.66	0.15	-1.46	0.51
EPS (Diluted)	-0.11	0.66	0.15	-1.46	0.51
EPS Growth	-	341.24%	-	-	68.42%
Dividend Per Share	0.246	0.216	0.248	0.352	0.360
Dividend Growth	13.89%	-12.90%	-29.54%	-2.22%	-
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	87.80%	86.96%	86.22%	85.66%	84.75%
Profit Margin	-24.23%	145.66%	35.95%	-334.78%	109.78%
EBIT	19.99	19.35	17.61	18.49	19.27
EBIT Margin	87.80%	86.96%	86.22%	85.66%	84.75%

SEC Filings: 10-K · 10-Q